My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 112

    1.

    Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions.

    Lux A, Llacer H, Heussen FM, Joussen AM.

    Br J Ophthalmol. 2007 Oct;91(10):1318-22. Epub 2007 May 30.PMID: 17537784 [PubMed - indexed for MEDLINE]Related articles

    2.

    Treatment of choroidal neovascularization using intravitreal bevacizumab.

    Pedersen R, Soliman W, Lund-Andersen H, Larsen M.

    Acta Ophthalmol Scand. 2007 Aug;85(5):526-33. Epub 2007 May 18.PMID: 17511757 [PubMed - indexed for MEDLINE]Related articles

    3.

    A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations.

    Algvere PV, Steén B, Seregard S, Kvanta A.

    Acta Ophthalmol. 2008 Aug;86(5):482-9. Epub 2007 Dec 14.PMID: 18162062 [PubMed - indexed for MEDLINE]Related articles

    4.

    A study comparing two protocols of treatment with intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

    Arias L, Caminal JM, Casas L, Masuet C, Badia MB, Rubio M, Pujol O, Arruga J.

    Br J Ophthalmol. 2008 Dec;92(12):1636-41. Epub 2008 Sep 9.PMID: 18782803 [PubMed - indexed for MEDLINE]Related articles

    5.

    Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

    Retina. 2007 Apr-May;27(4):432-8.PMID: 17420694 [PubMed - indexed for MEDLINE]Related articles

    6.

    Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome.

    Ruiz-Moreno JM, Montero JA, Gomez-Ulla F, Ares S.

    Br J Ophthalmol. 2009 Apr;93(4):448-51. Epub 2008 Dec 17.PMID: 19091851 [PubMed - indexed for MEDLINE]Related articles

    7.

    Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.

    Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA; Pan-American Collaborative Retina Study Group.

    Retina. 2008 Nov-Dec;28(10):1387-94.PMID: 18827735 [PubMed - indexed for MEDLINE]Related articles

    8.

    Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration.

    Lazic R, Gabric N.

    Graefes Arch Clin Exp Ophthalmol. 2007 Jan;245(1):68-73. Epub 2006 Nov 18.PMID: 17111146 [PubMed - indexed for MEDLINE]Related articles

    9.

    Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularisation in patients with angioid streaks.

    Wiegand TW, Rogers AH, McCabe F, Reichel E, Duker JS.

    Br J Ophthalmol. 2009 Jan;93(1):47-51. Epub 2008 Oct 29.PMID: 18971238 [PubMed - indexed for MEDLINE]Related articles

    10.

    Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

    Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ.

    Ophthalmology. 2006 Mar;113(3):363-372.e5. Epub 2006 Feb 3.PMID: 16458968 [PubMed - indexed for MEDLINE]Related articles

    11.

    Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.

    Ahmadieh H, Taei R, Soheilian M, Riazi-Esfahani M, Karkhaneh R, Lashay A, Azarmina M, Dehghan MH, Moradian S.

    BMC Ophthalmol. 2007 Jun 7;7:10.PMID: 17555600 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.

    Emerson MV, Lauer AK, Flaxel CJ, Wilson DJ, Francis PJ, Stout JT, Emerson GG, Schlesinger TK, Nolte SK, Klein ML.

    Retina. 2007 Apr-May;27(4):439-44.PMID: 17420695 [PubMed - indexed for MEDLINE]Related articles

    13.

    Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.

    Chan WM, Lai TY, Liu DT, Lam DS.

    Ophthalmology. 2007 Dec;114(12):2190-6. Epub 2007 Jun 28.PMID: 17599414 [PubMed - indexed for MEDLINE]Related articles

    14.

    Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.

    Chan WM, Lai TY, Liu DT, Lam DS.

    Am J Ophthalmol. 2007 Jun;143(6):977-983. Epub 2007 Apr 24.PMID: 17459318 [PubMed - indexed for MEDLINE]Related articles

    15.

    Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration.

    Aisenbrey S, Ziemssen F, Völker M, Gelisken F, Szurman P, Jaissle G, Grisanti S, Bartz-Schmidt KU.

    Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):941-8. Epub 2006 Dec 21.PMID: 17186262 [PubMed - indexed for MEDLINE]Related articles

    16.

    Intravitreal bevacizumab for the treatment of feeder vessel of subfoveal choroidal neovascularization.

    Theodossiadis PG, Grigoropoulos VG, Emfietzoglou I, Vergados J, Chalkiadakis J, Theodossiadis GP.

    Eur J Ophthalmol. 2007 Sep-Oct;17(5):853-6.PMID: 17932868 [PubMed - indexed for MEDLINE]Related articles

    17.

    Combined intravitreal bevacizumab and photodynamic therapy for neovascular age-related macular degeneration.

    Ladewig MS, Karl SE, Hamelmann V, Helb HM, Scholl HP, Holz FG, Eter N.

    Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):17-25. Epub 2007 Aug 15.PMID: 17701197 [PubMed - indexed for MEDLINE]Related articles

    18.

    Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.

    Chan CK, Meyer CH, Gross JG, Abraham P, Nuthi AS, Kokame GT, Lin SG, Rauser ME, Kaiser PK.

    Retina. 2007 Jun;27(5):541-51.PMID: 17558314 [PubMed - indexed for MEDLINE]Related articles

    19.

    Treatment of peripapillary choroidal neovascular membranes with intravitreal bevacizumab.

    Figueroa MS, Noval S, Contreras I.

    Br J Ophthalmol. 2008 Sep;92(9):1244-7. Epub 2008 Jul 11.PMID: 18621798 [PubMed - indexed for MEDLINE]Related articles

    20.

    Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study.

    Bashshur ZF, Haddad ZA, Schakal A, Jaafar RF, Saab M, Noureddin BN.

    Am J Ophthalmol. 2008 Feb;145(2):249-256. Epub 2007 Dec 11.PMID: 18067876 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity